Evaluation of Three Types of Dressings After Hip Surgery

NCT ID: NCT01469871

Last Updated: 2011-11-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-02-28

Study Completion Date

2010-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if one of the new types of dressings (MEPORE PRO and/or MEPILEX BORDER ) will reduce the blister rate compared to the currently used HYPAFIX.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tape Blisters Hip Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hypafix Transparent dressing

The Hypafix Transparent dressing, a stretchable dressing, will be used to treat the patients in this group

Group Type ACTIVE_COMPARATOR

Dressing of wound

Intervention Type DEVICE

The wound will be dressed using the Hypafix Transparent dressing after hip surgery.

Mepore Pro dressing

The Mepore Pro dressing, a self-adhesive perforated dressing, will be used to treat the patients in this group

Group Type ACTIVE_COMPARATOR

Dressing of wound

Intervention Type DEVICE

The wound will be dressed using the Mepore Pro dressing after hip surgery.

Mepilex Border dressing

The Mepilex Border dressing, a self-adherent soft silicone dressing, will be used to treat the patients in this group

Group Type ACTIVE_COMPARATOR

Dressing of wound

Intervention Type DEVICE

The wound will be dressed using the Mepilex Border dressing after hip surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dressing of wound

The wound will be dressed using the Hypafix Transparent dressing after hip surgery.

Intervention Type DEVICE

Dressing of wound

The wound will be dressed using the Mepore Pro dressing after hip surgery.

Intervention Type DEVICE

Dressing of wound

The wound will be dressed using the Mepilex Border dressing after hip surgery.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or Female 45 years old or older
* Hip surgery at Hopital de l'Enfant-Jesus between 02/2009 and 01/2010 (THR,rTHR, DHS, screw fixation, hemiarthroplasty, resurfacing)
* Signed consent form

Exclusion Criteria

* Allergy to dressing
* Polytrauma / high energy trauma
* Wound at the surgical site prior to surgery
* Neurological deficit of operated side (hemiplegia, etc.)
* Bilateral fracture
Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hopital de l'Enfant-Jesus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pelet Stephane

Dr Stephane Pelet MD, PhD Orthopedic surgeon

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephane Pelet, MD,PhD

Role: PRINCIPAL_INVESTIGATOR

Hopital l'Enfant-Jésus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre hospitalier affilié universitaire de Quebec - Hopital l'Enfant-Jesus

Québec, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEJ-481

Identifier Type: -

Identifier Source: org_study_id